Arancia G, Leonetti C, Malorni W, Greco C, Formisano G, Marangolo M, Zupi G
Department of Ultrastructures, Istituto Superiore di Sanità, Rome, Italy.
J Cancer Res Clin Oncol. 1991;117(4):351-8. doi: 10.1007/BF01630719.
The effects of the combination of N-methylformamide (NMF) with 5-fluorouracil (5-FU) on tumor growth and morphological features of human colon carcinoma cells (HT29) implanted in nude mice were assessed. Both agents were administered i.p. at tolerable doses: 5-FU at 19 mg/kg for 5 days and NMF at 200 mg/kg for 12 days. Four main schedules were tested: 5-FU alone, NMF alone, NMF followed by 5-FU and 5-FU followed by NMF. The last sequence was the most effective, as compared with the other treatment regimens. In particular, the 5-FU----NMF combination induced a tumor inhibition of about 75% at the end of the treatments (17th day) versus an inhibition of 23%-43% in the other schedules. Morphological observations, carried out by light and electron microscopy, indicated a possible relationship between the presence of structural changes and tumor growth inhibition. The results of this study renew interest in the use of NMF in sequential combination confirming sequence as a critical factor for the optimal combination of NMF and 5-FU.
评估了N-甲基甲酰胺(NMF)与5-氟尿嘧啶(5-FU)联合使用对裸鼠体内植入的人结肠癌细胞(HT29)肿瘤生长及形态特征的影响。两种药物均通过腹腔注射给予可耐受剂量:5-FU为19 mg/kg,持续5天;NMF为200 mg/kg,持续12天。测试了四种主要给药方案:单独使用5-FU、单独使用NMF、NMF后使用5-FU以及5-FU后使用NMF。与其他治疗方案相比,最后一种给药顺序最为有效。特别是,在治疗结束时(第17天),5-FU-NMF联合用药诱导的肿瘤抑制率约为75%,而其他给药方案的抑制率为23%-43%。通过光学显微镜和电子显微镜进行的形态学观察表明,结构变化的存在与肿瘤生长抑制之间可能存在关联。本研究结果重新引发了对NMF序贯联合使用的兴趣,证实给药顺序是NMF与5-FU最佳联合使用的关键因素。